Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 2Stomach Neoplasms 1Psychological Well-Being 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Lung Neoplasms 1Leiomyoma 1Inflammation 1Helicobacter Infections 1Esophageal Neoplasms 1Colonic Neoplasms 1Anovulation 1

Interventions

Oxaliplatin 13Bevacizumab 11Capecitabine 10Fluorouracil 8Blood Specimen Collection 8Leucovorin 7Cetuximab 6pembrolizumab 5Folfox protocol 5trifluridine tipiracil drug combination 4dostarlimab 4Nivolumab 4Irinotecan 4HMPL-013 4Drug Therapy 4fludarabine 3XELOX 3Specimen Handling 3Laparoscopy 3IFL protocol 3Cyclophosphamide 3Biopsy 3tislelizumab 2tipiracil 2regorafenib 2pertuzumab 2envafolimab 2encorafenib 2cemiplimab 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Colonic Neoplasms × Vitamin D × Clear all
NCT07534852 2026-04-16

NIMA

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Phase NA Recruiting
120 enrolled
Gastrointestinal

Colonic Neoplasms, Inflammation, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡